Article
Single‐cell RNA‐seq reveals clonal diversity and prognostic genes of relapsed multiple myeloma
1 Mar 2022
Abstract excerpt
BACKGROUND: Multiple myeloma (MM) is a clinically and biologically heterogeneous plasma-cell malignancy. Despite extensive research, disease heterogeneity and relapse remain a big challenge in MM therapeutics. We tried to dissect this disease and identify novel biomarkers for patient stratification and treatment outcome prediction by applying single-cell technology. METHODS: We performed single-cell RNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
